Our study (2018) n=139 |
Perceval S |
3.26 (0.53-18.8) |
40 (21-114) |
63 (25-172) |
4 (2.8%) |
5 (3.6%) |
3 (2.1%) |
12.5 (6-18) |
1.5 |
D'Onofrio[1313 D'Onofrio A, Messina A, Lorusso R, Alfieri OR, Fusari M, Rubino P, et al. Sutureless aortic valve replacement as an alternative treatment for patients belonging to the "gray zone" between transcatheter aortic valve implantation and conventional surgery: a propensity-matched, multicenter analysis. J Thorac Cardiovasc Surg. 2012;144(5):1010-6.] (2012) n=51 |
Perceval S |
14.2±8.1 |
44±17 |
69±26 |
|
2 (5.3%) |
0 |
10.9±3.72 |
|
Folliguet[1414 Folliguet TA, Laborde F, Zannis K, Ghorayeb G, Haverich A, Shrestha M. Sutureless Perceval aortic valve replacement: results of two European centers. Ann Thorac Surg. 2012;93(5):1483-8.] (2012) n=208 |
Perceval S |
8.7±5.3 |
30.1±12.2 |
50.3±22.8 |
9 (4.3%) |
16 (7.7%) |
5 (2.4%) |
10.4±4.3 |
1.4±0.4 |
Kocher[2020 Kocher AA, Laufer G, Haverich A, Shrestha M, Walther T, Misfeld M; et al. One-year outcomes of the Surgical Treatment of Aortic Stenosis with a Next Generation Surgical Aortic Valve (TRITON) trial: a prospective multicenter study of rapid-deployment aortic valve replacement with the EDWARDS INTUITY Valve System. J Thorac Cardiovasc Surg. 2013;145(1):110-5.] (2013) n=146 |
Edwards Intuity |
7.9±6.5 |
41.1±10.6 |
66.3±18.7 |
2 (1.9%) but after 30 days |
10 (7.1%) |
3 (2.1) |
8.8±3.0 |
1.7±0.2 |
Martens[2121 Martens S, Sadowski J, Eckstein FS, Bartus K, Kapelak B, Sievers HH, et al. Clinical experience with the ATS 3f Enable(r) Sutureless Bioprosthesis. Eur J Cardiothorac Surg. 2011;40(3):749-55.] (2011) n=140 |
ATS 3f Enable |
|
58.1±25.1Including combined procedures |
84.9±34.2Including combined procedures |
3 (2.1%) |
|
5 (3.6%) |
10.24±4.2 |
1.75±0.45 |
Santarpino[2222 Santarpino G, Pfeiffer S, Schmidt J, Concistrè G, Fischlein T. Sutureless aortic valve replacement: first-year single-center experience. Ann Thorac Surg. 2012;94(2):504-8.] (2012) n=83 |
Perceval S |
10±7.5 |
36±12.7 |
66±21 |
1 (1.2%) |
3 (3.6%) |
2 (2.4%) |
13.4±2.8 |
|
Flameng[1818 Flameng W, Herregods MC, Hermans H, Van der Mieren G, Vercalsteren M, Poortmans G, et al. Effect of sutureless implantation of the Perceval S aortic valve bioprosthesis on intraoperative and early postoperative outcomes. J Thorac Cardiovasc Surg. 2011;142(6):1453-7.] (2011) n=32 |
Perceval S |
9.99 |
17 (12-34) |
46(24-120) |
|
1 (3.1%) 6-12 months after surgery |
3 (9.4%) 6-12 months after surgery |
|
1.5 (0.8-2.2) |
Shrestha[88 Shrestha M, Folliguet TA, Pfeiffer S, Meuris B, Carrel T, Bechtel M, et al. Aortic valve replacement and concomitant procedures with the Perceval valve: results of European Trials. Ann Thorac Surg. 2014;98(4):1294-300.] (2014) n=243 |
Perceval S |
12.1 |
50.7±22.8 including combined procedures |
78.9±32.3 including combined procedures |
4 (1.6%) |
14 (5.9%) |
5(2.1%) |
10.1 ± 4.7 |
1.5 ± 0.4 |
Cavalier trial[1919 Laborde F, Fischlein T, Hakim-Meibodi K, Misfeld M, Carrel T, Zembala M, et al; Cavalier Trial Investigators. Clinical and haemodynamic outcomes in 658 patients receiving the Perceval sutureless aortic valve: early results from a prospective European multicentre study (the Cavalier Trial). Eur J Cardiothorac Surg. 2016;49(3):978-86.] (2016) n = 658 |
Perceval S |
10.2±7.8 |
35.3±12.1 |
58.4±20.2 |
5 (0.8) |
42 (6.7%) |
23 (3.7) |
10.24 |
1.46 |
Gilmanov[2323 Gilmanov D, Miceli A, Ferrarini M, Farneti P, Murzi M, Solinas M, et al. Aortic valve replacement through right anterior minithoracotomy: can sutureless technology improve clinical outcomes? Ann Thorac Surg. 2014;98(5):1585-92.] (2014) n=133 |
Predominantly Perceval S |
7.5 (4.8-11) |
56 (48-72.5) |
90 (78-108.5) |
|
3 (2.3%) |
2 (1.5) |
12 |
|
Pollari[1616 Pollari F, Santarpino G, Dell'Aquila AM, Gazdag L, Alnahas H, Vogt F. Better short-term outcome by using sutureless valves: a propensity-matched score analysis. Ann Thorac Surg. 2014;98(2):611-6.] (2014) n=133 |
Perceval S |
14±7.4 |
35±12 |
71±11 |
0 |
5 (6.1%) |
|
|
|
Dalén[2424 Dalén M, Biancari F, Rubino AS, Santarpino G, Glaser N, De Praetere H, et al. Aortic valve replacement through full sternotomy with a stented bioprosthesis versus minimally invasive sternotomy with a sutureless bioprosthesis. Eur J Cardiothorac Surg. 2016;49(1):220-7.] (2016) n=182 |
Perceval S |
10.6±7.5 |
41±17 |
69±23 |
|
|
3 (1.6) |
|
|